ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $14,000 | -65.0% | 10,459 | -53.8% | 0.00% | – |
| Q4 2021 | $40,000 | +60.0% | 22,622 | +93.4% | 0.00% | – |
| Q3 2021 | $25,000 | -41.9% | 11,698 | -4.3% | 0.00% | – |
| Q2 2021 | $43,000 | -63.6% | 12,228 | +2.3% | 0.00% | -100.0% |
| Q1 2021 | $118,000 | -16.3% | 11,953 | -8.1% | 0.00% | -20.0% |
| Q4 2020 | $141,000 | +9.3% | 13,006 | +3.9% | 0.01% | -16.7% |
| Q3 2020 | $129,000 | -43.4% | 12,518 | +14.5% | 0.01% | -45.5% |
| Q2 2020 | $228,000 | +117.1% | 10,932 | +1.8% | 0.01% | +266.7% |
| Q1 2020 | $105,000 | -10.3% | 10,738 | +5.5% | 0.00% | +50.0% |
| Q4 2019 | $117,000 | – | 10,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |